Testing effectiveness (Phase 2)Not Yet RecruitingNCT07653438
What this trial is testing
In Vivo Fluorescence Molecular Bronchoscopy of Durvalumab-680LT in Patients With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) After Chemoradiotherapy
Who this might be right for
Stage III Non-small Cell Lung CancerUnresectable Stage III NSCLC
University Medical Center Groningen 20